Sign in

CIK 0000875045

  • Large accelerated filer

BIOGEN INC.

Sign in to watch
Ticker
BIIB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330112644
Phone
+1 617-679-2000
Business address
225 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2016-06-06 Koppel Adam EVP, Strategy and Bus. Dev. Sale −555 $290.00 $161K 2,402.11
2016-06-02 Koppel Adam EVP, Strategy and Bus. Dev. Exercise or conversion +1,643 3,491.11
2016-06-02 Koppel Adam EVP, Strategy and Bus. Dev. Shares withheld for taxes −534 $289.73 $155K 2,957.11
2016-06-02 Koppel Adam EVP, Strategy and Bus. Dev. Exercise or conversion · Restricted Stock Unit −1,643 5,585
2016-06-02 Koppel Adam EVP, Strategy and Bus. Dev. Other disposition · Restricted Stock Unit −1,969 3,616
2016-04-06 Koppel Adam EVP, Strategy and Bus. Dev. Sale −102 $275.00 $28K 1,848.11
2016-02-23 Koppel Adam EVP, Strategy and Bus. Dev. Exercise or conversion +301 1,963.26
2016-02-23 Koppel Adam EVP, Strategy and Bus. Dev. Shares withheld for taxes −98 $258.99 $25K 1,865.26
2016-02-23 Koppel Adam EVP, Strategy and Bus. Dev. Exercise or conversion · Restricted Stock Unit −301 2,399
2016-02-23 Koppel Adam EVP, Strategy and Bus. Dev. Other disposition · Restricted Stock Unit −597 1,802
2016-02-22 Koppel Adam EVP, Strategy and Bus. Dev. Grant or award · Restricted Stock Unit +7,270 7,270

Page 1 of 1 · 11 trades